EUROIMMUN Anti-SARS-CoV-2 ELISA (IgG)
ProterixBio provides the Euroimmun US Anti-SARS-CoV-2 ELISA (IgG) for the detection of antibodies to the virus that causes Covid-19, SARS-CoV-2. This test has been made available by FDA under an emergency access mechanism called an Emergency Use Authorization (EUA).
If you are a healthcare provider, please refer to the Fact Sheet for Healthcare Providers available on the FDA website at https://www.fda.gov/media/137607/download.
If you are a test recipient, please refer to the Fact Sheet for Recipients available on the FDA website at https://www.fda.gov/media/137608/download.
This test is available by prescription only.
ProterixBio offers the Euroimmun US Anti-SARS-CoV-2 ELISA (IgG) as a testing service through its high-complexity CLIA laboratory, (#22D2189261), which is licensed in all 50 States.
If you are interested in ordering a test or would like to request additional information, please contact us.